INFORMAZIONI SU QUESTO EPISODIO
Host: Alexandria May, PharmD, BCPS
Guest: Kaitlin Batley, MD
Guest: Kaitlin Batley, MD
Fatigue and muscle weakness may seem routine, but when do they signal an underlying condition like thymidine kinase 2 deficiency (TK2d)? To find out, Dr. Alexandria May speaks with Dr. Kaitlin Batley, Director of the Pediatric Neuromuscular Program at Children’s Health and an Assistant Professor of Pediatrics and Neurology at UT Southwestern Medical Center. They discuss how multisystem involvement can help distinguish TK2d from more common neuromuscular disorders and how we can achieve diagnostic clarity through advanced genetic testing, metabolic evaluation, and muscle biopsy.
Inglese
Stati Uniti
IN QUESTO EPISODIO
TRASCRIZIONE 🔗
Are you the producer of this podcast?
Add a podcast transcript
Need Audio-to-Text?
Transcribe with Listen411 in Just 60 Seconds
CERCA TRA GLI EPISODI PASSATI
Cerca gli episodi passati di NeuroFrontiers.
ALTRI EPISODI IN QUESTO PODCAST
Guest: Henry Kaminski, MD
Myasthenia gravis is an unpredictable condition, with symptoms and treatment responses that can vary widely from one patient to the next. Tune in to hear Dr. Henry Kaminski explain how to navigate this variability and make thoughtful, individualized treatment de…
Guest: Mark Freedman, HBSc, MSc, MD, CSPQ, FAAN, FRCPC
The role of cell-based therapies in multiple sclerosis (MS) is evolving, with immune system replacement via autologous stem cells, investigational mesenchymal repair strategies, and CAR T-cell approaches changing the treatment …
Host: Brian P. McDonough, MD, FAAFP
Guest: Austin Larson, MD
Emerging research on thymidine kinase 2 deficiency (TK2d) provides new insights into its global genetic prevalence and variability across genetic ancestries. By combining clinical literature with large genomic databases, in…
Guest: Mark Freedman, HBSc, MSc, MD, CSPQ, FAAN, FRCPC
Cxplore how cell-based therapies are reshaping treatment strategies for multiple sclerosis (MS). Hear from Dr. Mark Freedman as he examines the scientific rationale behind emerging strategies. Dr. Freedman is a Profes…
Dichiarazione di non responsabilità: Il podcast e la grafica incorporati in questa pagina provengono da ReachMD, che è di proprietà del suo proprietario e non è affiliato o approvato da Listen Notes, Inc.
MODIFICA
Grazie, ci hai aiutato a mantenere aggiornato il database dei podcast.
